EUVIMEDEUVIMED entdecken
Crossref

Proteomic changes of botulinum neurotoxin injection on muscle growth in children with spastic cerebral palsy

Xubo Yang, Hongmei Tang, Lu He, Tingting Peng, Jinling Li, Jingbo Zhang, Liru Liu, Hongyu Zhou, Zhaofang Chen, Jingyi Zhao, Yage Zhang, Mengru Zhong und 4 weitere

PROTEOMICS – Clinical Applications · 2024

DOI: 10.1002/prca.202300070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, 2024. Verfasst von Xubo Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Cerebral Palsy, Proteomics, Botulinum Toxins, Type A, Muscle Spasticity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, Guangzhou Science Technology and Innovation Development Fund, Featured Clinical Technique of Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The study aims to explore the proteomic profile and specific target proteins associated with muscle growth in response to botulinum neurotoxin A (BoNT‐A) treatment, in order to improve spasticity management in children with cerebral palsy (CP). Experimental design A total of 54 participants provided 60 plasma samples for proteomic analysis. Among them, six children were sampled before and after receiving their first BoNT‐A injection. In addition, 48 unrelated children were enrolled, among whom one group had never received BoNT‐A injections and another group was sampled after their first BoNT‐A injection. Differentially expressed proteins were identified using the data‐independent acquisition (DIA) mass spectrometry approach. Gene Ontology (GO), protein–protein interaction network, and Kyoto Encyclopedia of Genes and Genome analysis were conducted to explore the function and relationship among differentially expressed proteins. The expression levels of target proteins were verified by quantitative real‐time PCR and western blotting.

Results

Analysis identified significant differential expression of 90 proteins across two time points, including 48 upregulated and 42 downregulated proteins. The upregulated thioredoxin, α‐actinin‐1, and aggrecan, and the downregulated integrin beta‐1 may affect the growth of muscles affected by spasticity 3 months after BoNT‐A injection. This effect is potentially mediated through the activation or inhibition of PI3K‐Akt, focal adhesion, and regulation of actin cytoskeleton signaling pathways. Conclusion and clinical relevance BoNT‐A injection could lead to a disruption of protein levels and signaling pathways, a condition subsequently associated with muscle growth. This finding might aid clinicians in optimizing the management of spasticity in children with CP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral PalsyProteomicsBotulinum Toxins, Type AMuscle SpasticityHumansMaleFemaleChildChild, PreschoolMuscle, SkeletalProtein Interaction Maps

Stichwörter der Autor:innen

botulinum neurotoxin Acerebral palsydata‐independent acquisition mass spectroscopy analysismuscle growthproteomics

Substanzen

Botulinum Toxins, Type A

Autor:innen und Institutionen

  • Department of Rehabilitation, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Department of Sport Rehabilitation, Shanghai University of Sport, shanghai, China.
  • Genechem Biotechnology Co., Ltd, Shanghai, China.

ORCID-Profile: Kaishou Xu

Förderung

  • Natural Science Foundation of Guangdong Province
  • Guangzhou Science Technology and Innovation Development Fund
  • Featured Clinical Technique of Guangzhou
  • Science and Technology Program of Guangzhou

Zitieren

APA

Yang, X., Tang, H., He, L., Peng, T., Li, J., Zhang, J., Liu, L., Zhou, H., Chen, Z., Zhao, J., Zhang, Y., Zhong, M., Han, M., Zhang, M., Niu, H., & Xu, K. (2024). Proteomic changes of botulinum neurotoxin injection on muscle growth in children with spastic cerebral palsy. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.202300070

Vancouver

Yang X, Tang H, He L, Peng T, Li J, Zhang J, et al. Proteomic changes of botulinum neurotoxin injection on muscle growth in children with spastic cerebral palsy. PROTEOMICS – Clinical Applications. 2024. doi:10.1002/prca.202300070

BibTeX
@article{Yang2024,
  author = {Yang, Xubo and Tang, Hongmei and He, Lu and Peng, Tingting and Li, Jinling and Zhang, Jingbo and Liu, Liru and Zhou, Hongyu and Chen, Zhaofang and Zhao, Jingyi and Zhang, Yage and Zhong, Mengru and Han, Mingshan and Zhang, Mengqing and Niu, Huiran and Xu, Kaishou},
  title = {Proteomic changes of botulinum neurotoxin injection on muscle growth in children with spastic cerebral palsy},
  journal = {PROTEOMICS – Clinical Applications},
  year = {2024},
  doi = {10.1002/prca.202300070}
}
Kostenlos starten →